Similar to human imatinib-resistant patients with BCR-ABL1T315I+ disease, blasts were increased in the peripheral blood (Fig. S1E) and the BM of mice with BCR-ABL1T315I+ CML (Fig. 1h, i). This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.